Global Heart Failure Academy

Episodes 1-16 of 16

• • 

    

    Peter van der Meer, MD, PhD

    Peer

  • 

    

    Pieter Martens, MD, PhD

    Peer

  1

  

  RestartResume

  New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remodeling

  RestartResume

  New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remodeling

  0.25 credits

  New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remode…

  0.25 credits

• • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Piotr Ponikowski, MD, PHD, FESC, FHFA

    Peer

  1

  

  RestartResume

  Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart Failure

  RestartResume

  Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart Failure

  Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart…

• • 

    

    Gregg C. Fonarow, MD

    Peer

  • 

    

    Andrew J. S. Coats, MD

    Peer

  1

  

  RestartResume

  Applying Key Updates from ESC/HFA to Managing Heart Failure

  RestartResume

  Applying Key Updates from ESC/HFA to Managing Heart Failure

  0.25 credits

  Applying Key Updates from ESC/HFA to Managing Heart Failure

  0.25 credits

• • 

    

    Keith C. Ferdinand, MD

    Peer

  • 

    

    Marco Metra, MD

    Peer

  6

  

  RestartResume

  Managing HK in HF: Navigating the Evolving Clinical Landscape

  RestartResume

  Managing HK in HF: Navigating the Evolving Clinical Landscape

  0.25 credits

  Managing HK in HF: Navigating the Evolving Clinical Landscape

  0.25 credits

• • 

    

    Mikhail Kosiborod, MD

    Peer

  • 

    

    Ewa A. Jankowska, MD, PhD, FESC

    Peer

  • 

    

    Phil McEwan, PhD

    Peer

  1

  

  RestartResume

  Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact

  RestartResume

  Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact

  0.25 credits

  Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeco…

  0.25 credits

• • 

    

    Ileana L. Piña, MD, MPH, FAHA, FACC

    Peer

  • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

    Peer

  2

  

  RestartResume

  From Guidelines to Practice: Key Updates From 2021 HFSA

  RestartResume

  From Guidelines to Practice: Key Updates From 2021 HFSA

  0.25 credits

  From Guidelines to Practice: Key Updates From 2021 HFSA

  0.25 credits

• • 

    

    Ileana L. Piña, MD, MPH, FAHA, FACC

    Peer

  • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Gregg C. Fonarow, MD

    Peer

  • 

    

    Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

    Peer

  3

  

  RestartResume

  Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities to Improve Patient Outcomes

  RestartResume

  Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities to Improve Patient Outcomes

  1.50 credits

  Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities t…

  1.50 credits

• • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

    Peer

  • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

    Peer

  7

  

  RestartResume

  A New Normal? COVID-19 and HF in Clinical Trials

  RestartResume

  A New Normal? COVID-19 and HF in Clinical Trials

  0.25 credits

  A New Normal? COVID-19 and HF in Clinical Trials

  0.25 credits

• • 

    

    Robert J. Mentz, MD, FHFSA, FACC, FAHA

    Peer

  • 

    

    Peter van der Meer, MD, PhD

    Peer

  5

  

  RestartResume

  A Clinical Guide to the Role of Iron in HF Pathophysiology

  RestartResume

  A Clinical Guide to the Role of Iron in HF Pathophysiology

  0.25 credits

  A Clinical Guide to the Role of Iron in HF Pathophysiology

  0.25 credits

• • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA

    Peer

  3

  

  RestartResume

  Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders

  RestartResume

  Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders

  0.25 credits

  Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium B…

  0.25 credits

• • 

    

    Gregory Lewis, MD

    Peer

  • 

    

    Michael Böhm, MD, FESC

    Peer

  • 

    

    Josep Comin-Colet, MD, PhD

    Peer

  6

  

  RestartResume

  Die klinische Bedeutung der Behandlung von Eisenmangel laut AFFIRM-AHF

  RestartResume

  Die klinische Bedeutung der Behandlung von Eisenmangel laut AFFIRM-AHF

  0.25 credits

  Die klinische Bedeutung der Behandlung von Eisenmangel laut AFFIRM-AHF

  0.25 credits

• • 

    

    Ewa A. Jankowska, MD, PhD, FESC

    Peer

  8

  

  RestartResume

  AFFIRM-AHF: Key Takeaways

  RestartResume

  AFFIRM-AHF: Key Takeaways

  AFFIRM-AHF: Key Takeaways

• • 

    

    Stefan D. Anker, MD, PhD

    Peer

  • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Ewa A. Jankowska, MD, PhD, FESC

    Peer

  • 

    

    Josep Comin-Colet, MD, PhD

    Peer

  11

  

  RestartResume

  Late-breaking First Response on AFFIRM-AHF

  RestartResume

  Late-breaking First Response on AFFIRM-AHF

  Late-breaking First Response on AFFIRM-AHF

• • 

    

    Mikhail Kosiborod, MD

    Peer

  6

  

  RestartResume

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  RestartResume

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-d…
• 3

  

  RestartResume

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

  RestartResume

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

  Mechanisms in Heart Failure: Why Iron Deficiency Matters
• 2

  

  RestartResume

  Balancing RAASi Therapy and Potassium: Understanding How it Works

  RestartResume

  Balancing RAASi Therapy and Potassium: Understanding How it Works

  Balancing RAASi Therapy and Potassium: Understanding How it Works